A world-first trial of a next-generation cancer treatment which uses a tailored does of radioactive copper to target tumours is underway at Royal North Shore Hospital (RNSH). This new treatment approach had been developed in conjunction with Sydney Vital and Clarity Pharmaceuticals.
Sydney Vital Research Scholar Awards Round 9
Sydney Vital is pleased to invite our members to apply for our Research Scholarship Awards, Round 8.
Sydney Vital is pleased to invite applications for its Seed Funding Awards to the value of $50,000 each. The Sydney Vital Seed Funding Scheme intends to seed new ideas, with the goal of generating data to a point where external funding may be sought.
Sydney Vital invites applications for Travel Awards to the value of $1,500 for domestic travel and $3,000 for international travel.
Our aim is to encourage outstanding PhD students, ECRs, researchers and clinicians from within the Sydney Vital network and institutions to present their scientific research progress at national or international conferences.
A team of international collaborators under Sydney Vital’s Flagship 2, has won the 2nd prize in the 2nd International-Atom Indonesia Best Paper Awards 2018 (I-AIBPA 2018)
The Latest Developments in Immunotherapy – Basic Science, Transalational and Clinical: Immuno-Oncology Symposium
On Thursday, 29th November, Sydney Vital hosted an Immuno-Oncology Symposium, which aims at bringing up the Latest Developments in Immunotherapy- Basic Science, Translational and Clinical.